Jaguar Health (NASDAQ:JAGX) Now Covered by Analysts at LADENBURG THALM/SH SH

LADENBURG THALM/SH SH initiated coverage on shares of Jaguar Health (NASDAQ:JAGX) in a report issued on Thursday morning, The Fly reports. The firm issued a buy rating and a $5.00 target price on the biotechnology company’s stock.

Several other brokerages have also weighed in on JAGX. Zacks Investment Research lowered shares of Jaguar Health from a buy rating to a hold rating in a research report on Thursday, August 15th. ValuEngine raised Jaguar Health from a hold rating to a buy rating in a report on Thursday, August 1st. Finally, HC Wainwright set a $10.00 price objective on Jaguar Health and gave the stock a buy rating in a report on Tuesday, July 2nd.

NASDAQ:JAGX traded up $0.02 during trading hours on Thursday, hitting $1.33. 1,172,425 shares of the company traded hands, compared to its average volume of 440,586. The company has a quick ratio of 0.24, a current ratio of 0.35 and a debt-to-equity ratio of 0.02. The firm’s 50-day simple moving average is $1.36 and its 200-day simple moving average is $1.54. Jaguar Health has a one year low of $1.00 and a one year high of $175.00. The company has a market cap of $51.00 million, a PE ratio of -0.01 and a beta of 0.74.

In other news, Director James J. Bochnowski acquired 180,582 shares of the firm’s stock in a transaction on Tuesday, July 23rd. The stock was acquired at an average price of $2.00 per share, for a total transaction of $361,164.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 1.81% of the company’s stock.

About Jaguar Health

Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

Featured Article: Does the discount rate affect the economy?

The Fly

Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit